DMXi specializes in innovative oral care solutions through its proprietary peptide-guided remineralization technology, specifically the ADP5 platform. This technology is designed to enhance oral care products by providing effective remineralization, desensitization, and whitening capabilities. The company focuses on developing peptide formulations that can be integrated into both new and existing oral care products, catering to the needs of consumers, dental clinicians, and product manufacturers. DMXi's approach emphasizes a biomimetic solution to tooth decay, aiming to create healthier, stronger, and brighter teeth while partnering with other companies to optimize product design and manufacturing processes.

In addition to product development, DMXi is recognized as a leader in molecular biomimetics, leveraging extensive scientific research to support its technology. The company has published numerous studies in reputable scientific journals, detailing the efficacy of its peptide technology in promoting enamel remineralization and addressing dental issues. DMXi's expertise extends to prototyping, testing, and commercializing oral care products, ensuring that they meet regulatory requirements and perform effectively in the marketplace. Through its innovative approach, DMXi aims to revolutionize the oral care industry and contribute to a future with fewer cavities.

United States

DMXi makes oral care products based on peptides derived from the Amelogenin protein. Their products are designed to strenghen, desensitize, and brighten teeth.

DMXi

Company Details